Update on Clinical Outcomes of Highly Effective Modulator Therapy.

Abstract excerpt

Based on the cystic fibrosis transmembrane conductance regulator (CFTR) genotype, approximately 90% of people with cystic fibrosis (CF) are candidates for highly effective modulator therapy (HEMT). Clinical trials conducted over the last 11 years have shown that these oral therapies substantially restore CFTR function, leading to improvements in lung function, nutritional status, and health-related quality of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Child
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Transmembrane Conductance Regulator